Search
Wednesday 14 October 2015
  • :
  • :

Trending Stocks: Royal Caribbean Cruises Ltd (NYSE:RCL), Centene Corp (NYSE:CNC), CTI BioPharma Corp (NASDAQ:CTIC), Universal Health Services, Inc. (NYSE:UHS)

On Tuesday, Shares of Royal Caribbean Cruises Ltd (NYSE:RCL), lost -1.67% to $85.88.

Royal Caribbean, declared that Gary Bald, Senior Vice President, Safety, Security, Environment, Medical/Public Health and Situation Administration for Royal Caribbean Cruises Ltd., will transition his duties to top corporate and federal security executive Jennifer Love as he prepares for his retirement in the Spring of 2016. Love will join Royal Caribbean on September 28, 2015.

Bald has been with Royal Caribbean since 2006, overseeing environmental practices and stewardship in addition to the safety, security and health of the company’s 62,000 employees, more than five million guests annually, its fleet of 43 cruise ships and its shoreside facilities and terminals.

Royal Caribbean Cruises, Ltd. operates as a cruise company. The company operates cruisers under the Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Club Cruises, CDF Croisières de France, and TUI Cruises brand names.

Shares of Centene Corp (NYSE:CNC), inclined 0.49% to $52.91, during its last trading session.

Centene Corporation, declared that it will release its 2015 third quarter financial results at about 6:00 AM (Eastern Time) on Tuesday, October 27, 2015, and host a conference call afterwards at about 8:30 AM (Eastern Time) to review the results. Michael F. Neidorff, Chairman and Chief Executive Officer, and William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer, of Centene Corporation will host the call.

Centene Corporation operates as a diversified, multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates in two segments, Managed Care and Specialty Services.

At the end of Tuesday’s trade, Shares of CTI BioPharma Corp (NASDAQ:CTIC), lost -4.79% to $1.39.

CTI BioPharma Corp., declared that it has reached a contract with institutional investors to purchase 10 million shares of the Company’s common stock in a registered direct offering conducted without an underwriter or placement agent for gross proceeds to the Company of about $15.7 million at a purchase price per share of $1.57 (the “Offering”), equal to the merged closing bid price on The NASDAQ Global MarketSM on September 23, 2015. The net proceeds from the Offering, after deducting estimated offering expenses, will be about $15.1 million.

CTI BioPharma plans to use the net proceeds from the Offering to support the continued clinical development of its lead product candidate, pacritinib, as a potential new treatment for patients with myelofibrosis, and additional research into new indications outside of myelofibrosis, and for general corporate purposes. The Offering is predictable to close on or about September 29, 2015.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Finally, Universal Health Services, Inc. (NYSE:UHS), ended its last trade with -2.99% loss, and closed at $121.16.

Universal Health Services, declared that it has reached a definitive agreement and received FTC approval to purchase Foundations Recovery Network, LLC (“Foundations”) for a purchase price of about $350 million. Through this acquisition, we will add 322 residential beds in 4 facilities and 8 outpatient centers. In addition, there are over 140 expansion beds in the pipeline.

Foundations Recovery Network was founded in 1995 and is one of the premier names in addiction treatment. Their focus is on treating adults with co-occurring addiction and mental health disorders through an evidence-based integrated treatment model in residential and outpatient settings. With their sophisticated direct to consumer marketing model which comprises a call center, a national sales team and an industry leading web marketing program, the acquisition of Foundations will serve as a platform for growth in a new substance use disorder service line for UHS.

Universal Health Services, Inc., through its auxiliaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *